Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  2. Daily Adaptive Proton Therapy: Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Richard L Bakst
  • Bouthaina Shbib Dabaja
  • Lena K Specht
  • Joachim Yahalom
Vis graf over relationer

Survival times for patients with leukemia generally have improved in recent decades, and this improvement has been attributed to an enhanced understanding of the genetics driving the cause of the disease and improved combinations of chemotherapy and targeted therapy. Durable control of systemic disease in blood and bone marrow has significantly improved survival, but extramedullary relapse can pose therapeutic challenges for which radiation therapy can have an important role. This report discusses the current role of radiation therapy for patients with leukemia, specifically the extramedullary manifestations of leukemia.

TidsskriftInternational Journal of Radiation Oncology Biology Physics
Udgave nummer2
Sider (fra-til)314-319
Antal sider6
StatusUdgivet - 1 okt. 2018

ID: 55856678